Arch Gen Psychiatry -- Table of Contents (Vol. 44 No. 9, September 1987)

You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.

Table of Contents

ARTICLES

Does the dexamethasone suppression test relate to subtypes, factors, symptoms, or severity?
K. B. Miller; J. C. Nelson
Arch Gen Psychiatry. 1987;44:769-774.
ABSTRACT

Pituitary and adrenocortical responses to the ovine corticotropin releasing hormone in depressed patients and healthy volunteers
J. D. Amsterdam; G. Maislin; A. Winokur; M. Kling; P. Gold
Arch Gen Psychiatry. 1987;44:775-781.
ABSTRACT

The effects of dexamethasone on plasma homovanillic acid and 3-methoxy-4-hydroxyphenylglycol. Evidence for abnormal corticosteroid-catecholamine interactions in major depression
O. M. Wolkowitz; A. R. Doran; A. Breier; A. Roy; D. C. Jimerson; M. E. Sutton; R. N. Golden; S. M. Paul; D. Pickar
Arch Gen Psychiatry. 1987;44:782-789.
ABSTRACT

Neuroendocrine aspects of primary endogenous depression. II. Serum dexamethasone concentrations and hypothalamic-pituitary-adrenal cortical activity as determinants of the dexamethasone suppression test response
R. E. Poland; R. T. Rubin; I. M. Lesser; L. A. Lane; P. J. Hart
Arch Gen Psychiatry. 1987;44:790-795.
ABSTRACT

Dexamethasone suppression test and plasma dexamethasone levels in bulimia
B. T. Walsh; E. S. Lo; T. Cooper; D. C. Lindy; S. P. Roose; M. Gladis; A. H. Glassman
Arch Gen Psychiatry. 1987;44:797-800.
ABSTRACT

Afternoon continuous plasma levels of 3-methoxy-4-hydroxyphenylglycol and age. Distinctive biologic subgroups of endogenous depression?
U. Halbreich; N. Sharpless; G. M. Asnis; J. Endicott; S. Goldstein; J. Vital-Herne; J. Eisenberg; K. Zander; B. J. Kang; R. Shindledecker; al. et
Arch Gen Psychiatry. 1987;44:804-812.
ABSTRACT

Reliability of DSM-III diagnoses for major depression and generalized anxiety disorder using the structured clinical interview for DSM-III
J. H. Riskind; A. T. Beck; R. J. Berchick; G. Brown; R. A. Steer
Arch Gen Psychiatry. 1987;44:817-820.
ABSTRACT

Further measures of the psychometric properties of the Children's Global Assessment Scale
H. R. Bird; G. Canino; M. Rubio-Stipec; J. C. Ribera
Arch Gen Psychiatry. 1987;44:821-824.
ABSTRACT

Ontario Child Health Study. I. Methodology
M. H. Boyle; D. R. Offord; H. G. Hofmann; G. P. Catlin; J. A. Byles; D. T. Cadman; J. W. Crawford; P. S. Links; N. I. Rae-Grant; P. Szatmari
Arch Gen Psychiatry. 1987;44:826-831.
ABSTRACT

Ontario Child Health Study. II. Six-month prevalence of disorder and rates of service utilization
D. R. Offord; M. H. Boyle; P. Szatmari; N. I. Rae-Grant; P. S. Links; D. T. Cadman; J. A. Byles; J. W. Crawford; H. M. Blum; C. Byrne; al. et
Arch Gen Psychiatry. 1987;44:832-836.
ABSTRACT

Elevation of plasma homovanillic acid level can be detected within four hours after initiation of haloperidol treatment
R. Davila; M. Zumarraga; K. Perea; I. Andia; A. J. Friedhoff
Arch Gen Psychiatry. 1987;44:837-838.

Neuroleptic malignant syndrome
S. N. Caroff; S. C. Mann; A. Lazarus
Arch Gen Psychiatry. 1987;44:838-840.

Quantitative electroencephalography
M. R. Nuwer
Arch Gen Psychiatry. 1987;44:840.